TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Cand Pharm C. Cristoffersen AS
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
252,380
|
220,768
|
199,124 |
Financial expenses |
64
|
177
|
476 |
Earnings before taxes |
25,143
|
30,364
|
21,457 |
Total assets |
134,249
|
117,577
|
94,144 |
Current assets |
121,215
|
103,918
|
77,938 |
Current liabilities |
41,392
|
40,427
|
31,980 |
Equity capital |
92,857
|
77,151
|
62,164 |
- share capital |
2,643
|
2,564
|
2,386 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
69.2%
|
65.6%
|
66.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
10.0%
|
13.8%
|
10.8% |
Return on assets (ROA) |
18.8%
|
26.0%
|
23.3% |
Current ratio |
292.8%
|
257.1%
|
243.7% |
Return on equity (ROE) |
27.1%
|
39.4%
|
34.5% |
Change turnover |
24,771
|
6,865
|
26,249 |
Change turnover % |
11%
|
3%
|
15% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.